Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by Immunoassay
Also known as: HSV2 INHIB
Use
This assay is intended for samples giving a low positive index value in the HSV-2 type-specific IgG screening assay. It is used to differentiate true HSV-2 specific reactivity from falsely positive results in the screening assay. A positive inhibition interpretation confirms HSV-2 reactivity while a negative inhibition interpretation suggests a false positive screening index.
Special Instructions
The test is not performed at ARUP and requires separate specimens when multiple tests are ordered.
Limitations
This test is not a first-line test for herpes simplex virus (HSV) 2 typing. Inhibition studies are not performed on specimens with equivocal or negative results. The clinical interpretation of results should take into account patient history and clinical presentation.
New York Approved
Methodology
Immunoassay (Semi-Quantitative)
Biomarkers
LOINC Codes
- 43180-9
Result Turnaround Time
5-9 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Plain red or serum separator tube (SST)
Collection Instructions
Transfer 1 mL serum to an ARUP standard transport tube.
Storage Instructions
Refrigerated. Also acceptable: Room temperature or frozen.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Other tests from different labs that may be relevant